News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeurOp Corporation Names Robert Zaczek as Chief Scientific Officer


4/16/2012 10:16:26 AM

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. today announced that Robert Zaczek, Ph.D., has been named its chief scientific officer, a new role for the company. He will oversee the company’s drug research, which is focused on NMDA receptor modulation for the treatment of depression, neuropathic pain, ischemia (stroke), schizophrenia and other central nervous system disorders.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES